1,021,488 Shares in MetLife, Inc. $MET Bought by PFA Pension Forsikringsaktieselskab

Key Points

• PFA Pension acquired a new position of 1,021,488 shares of MetLife valued at about $81.5 million, representing roughly 0.16% of the company.
• MetLife beat quarterly estimates with $2.49 EPS vs. $2.34 expected and reported revenue of $52.44 billion (up 27.6% year-over-year), while analysts project about 9.85 EPS for the current fiscal year.
• MetLife raised its quarterly dividend to $0.5925 (annualized $2.37) for a ~3.0% yield, with an ex-dividend date of May 12 and payment on June 9.

PFA Pension Forsikringsaktieselskab acquired a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,021,488 shares of the financial services provider's stock, valued at approximately $81,494,000. PFA Pension Forsikringsaktieselskab owned about 0.16% of MetLife at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in MET. Providence Capital Advisors LLC acquired a new position in MetLife in the 3rd quarter worth approximately $6,649,000. Thrivent Financial for Lutherans boosted its stake in MetLife by 8.9% in the 3rd quarter. Thrivent Financial for Lutherans now owns 1,176,469 shares of the financial services provider's stock worth $96,905,000 after purchasing an additional 96,523 shares during the period. Nordea Investment Management AB boosted its stake in MetLife by 2.6% in the 4th quarter. Nordea Investment Management AB now owns 4,630,165 shares of the financial services provider's stock worth $366,524,000 after purchasing an additional 117,545 shares during the period. Varma Mutual Pension Insurance Co boosted its stake in MetLife by 21.9% in the 3rd quarter. Varma Mutual Pension Insurance Co now owns 137,956 shares of the financial services provider's stock worth $11,363,000 after purchasing an additional 24,800 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. boosted its stake in MetLife by 256.8% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 62,662 shares of the financial services provider's stock worth $5,161,000 after purchasing an additional 45,100 shares during the period. 94.99% of the stock is currently owned by institutional investors.

MetLife Stock Up 0.2%

MET stock opened at $80.29 on Friday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife, Inc. has a 1 year low of $67.33 and a 1 year high of $83.85. The company has a fifty day simple moving average of $73.14 and a 200 day simple moving average of $76.60. The firm has a market cap of $52.36 billion, a PE ratio of 17.08, a PEG ratio of 0.71 and a beta of 0.78.

MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion during the quarter, compared to analyst estimates of $31.43 billion. During the same quarter in the previous year, the business earned $2.08 EPS. MetLife's quarterly revenue was up 27.6% compared to the same quarter last year. Sell-side analysts anticipate that MetLife, Inc. will post 9.85 EPS for the current fiscal year.

MetLife Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 9th. Investors of record on Tuesday, May 12th will be paid a $0.5925 dividend. This represents a $2.37 annualized dividend and a dividend yield of 3.0%. The ex-dividend date of this dividend is Tuesday, May 12th. This is a boost from MetLife's previous quarterly dividend of $0.57. MetLife's dividend payout ratio (DPR) is presently 48.30%.

Trending Headlines about MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: Analysts expect higher net investment income and a consensus EPS uptick for Q1, boosting the odds of an earnings beat and supporting valuation multiple expansion. Can Higher Investment Income Help MetLife Deliver a Q1 Earnings Beat?
• Positive Sentiment: HCLTech expanded its partnership around MetLife Stadium and became an official AI partner for the Jets and Giants — a branding and technology deal that increases visibility and could create tech-driven revenue/efficiency opportunities for stadium-related services. HCLTech expands Cornerstone Partnership with MetLife Stadium
• Positive Sentiment: MetLife was ranked "best for multiple pets" in a 2026 ranking — a positive signal for momentum in its pet-insurance product line and distribution/brand strength in a growing segment. MetLife named best for multiple pets in 2026 ranking
• Neutral Sentiment: Analyst note exploring metrics beyond revenue and EPS highlights items investors should watch in the Q1 report (reserve development, spread income and capital deployment) — useful for interpreting the quarter but neutral until results are released. Exploring Analyst Estimates for MetLife (MET) Q1 Earnings, Beyond Revenue and EPS
• Neutral Sentiment: Oxford Properties hired a former MetLife executive as its U.S. head — a routine industry move that signals MetLife talent is valued externally but has limited near-term impact on MET's fundamentals. Oxford Properties Hires MetLife Exec As New Head Of U.S.
• Neutral Sentiment: MetLife paid cash for a 140-unit Peoria apartment complex — shows continued deployment into real assets; a modest capital-allocation item that is unlikely to move the stock materially by itself. MetLife Drops Cash on 140-Unit Peoria Villa Enclave
• Negative Sentiment: Sun Life reached a settlement in a class-action tied to legacy policies originally from MetLife — highlights ongoing legal/resolution risk tied to past products and could keep a watchlist on reserve or reputational impacts. Sun Life Reaches Settlement in Class Action Case Related to Policies From MetLife

Analyst Ratings Changes

A number of equities analysts recently commented on MET shares. TD Cowen decreased their price objective on shares of MetLife from $91.00 to $88.00 and set a "buy" rating for the company in a research note on Wednesday, March 11th. Barclays decreased their target price on shares of MetLife from $92.00 to $89.00 and set an "overweight" rating for the company in a research note on Wednesday, April 8th. Weiss Ratings lowered shares of MetLife from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, March 9th. Wall Street Zen raised shares of MetLife from a "hold" rating to a "buy" rating in a research note on Saturday, April 11th. Finally, Morgan Stanley decreased their target price on shares of MetLife from $101.00 to $93.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, MetLife currently has a consensus rating of "Moderate Buy" and an average price target of $93.38.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.